+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Cancer Immunotherapy Market Report 2026 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Checkpoint Inhibitors Market Report 2026 - Product Thumbnail Image

Checkpoint Inhibitors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drugs for Immunotherapy Market Report 2026 - Product Thumbnail Image

Drugs for Immunotherapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Market Report 2026 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Paranasal Sinus Cancer Market Report 2026 - Product Thumbnail Image

Paranasal Sinus Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immuno-Oncology Drugs Market Report 2026 - Product Thumbnail Image

Immuno-Oncology Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Metastatic Cancer Drugs Market Report 2026 - Product Thumbnail Image

Metastatic Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Gastric Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer Market - Global Strategic Business Report

  • Report
  • May 2026
  • 582 Pages
  • Global
From
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • May 2026
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • May 2026
  • 282 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more